Investigators sampled wastewater across four municipal sewersheds in El Paso, Texas, to measure community-level nicotine exposure. Samples were 24-hour composite influent collected monthly from June 2024 to May 2025 (n=48). The study integrated environmental surveillance with clinical records to test whether population biomarkers present in sewage correspond with local cardiovascular disease patterns.
The laboratory quantified five nicotine metabolites by liquid chromatography–tandem mass spectrometry. Cotinine, nornicotine, and trans-3-hydroxycotinine (3HC) were detected in 91.6% to 100% of samples. Tobacco-specific nitrosamines were reportedly below the limit of detection. The authors did not provide additional analytic validation details, such as limits of quantification for each analyte, in the source text.
Clinical data derived from the Paso del Norte Health Information Exchange covered January 2021 through December 2024. The study team mapped CVD cases to sewersheds using residential ZIP code boundaries and ArcGIS. The source indicates that case counts were normalized to sewershed populations for cross-area comparisons. The preprint states that ethical approval was granted by the Paso del Norte Health Information Exchange; no individual-level identifiers were disclosed outside the research group.
At the sewershed scale, population-normalized nicotine mass loads tracked proportional burdens of several cardiovascular disease categories, including atherosclerosis/ischemia/infarction and heart failure. The manuscript reports that these environmental loads moved in parallel with sewershed-level clinical burdens—suggesting that wastewater signals reflect aggregate tobacco exposure and its downstream cardiovascular consequences. The authors did not report longitudinal lag analyses or causal attribution beyond the observed correlations.
Across the four sewersheds, monthly 3HC mass load and the nicotine metabolite ratio (NMR) showed strong and specific associations with incident ST-elevation myocardial infarction (STEMI). The source reports a correlation between 3HC and STEMI with rho=0.893 and p=0.012. The study team observed no parallel associations for non–ST-elevation myocardial infarction or for older myocardial infarction diagnoses. The preprint does not detail additional multivariable models, adjustment covariates, or sensitivity analyses in the abstract and main body provided.
Authors noted that integrated wastewater and EHR surveillance can offer an objective, population-level metric of tobacco exposure that complements self-report and retail-sales data. They framed wastewater monitoring as a tool that could inform community cessation strategies and cardiovascular disease prevention at the population level. The source positions 3HC and NMR in sewage as potential community indicators for incident STEMI, and suggests public health programs might use those signals to target interventions; the preprint did not specify operational thresholds or intervention algorithms.
The preprint documents ethical approvals and data availability but does not include a structured limitations section or list specific next regulatory milestones. The authors did not report analytic limits of detection for each metabolite in the main text provided here, nor did they provide detailed confounder adjustment or temporal lag modeling for exposure-to-event inference. Therefore, unanswered questions remain within the source: how stable are wastewater nicotine signals over longer intervals, what lead time (if any) precedes clinical events like STEMI, and which covariates might modify the observed correlations? The source did not report those follow-up plans or regulatory steps.
Data and code availability were addressed: the authors indicated that analysis scripts will be posted on GitHub upon publication and that all analyzed data are included within the article and supplementary materials. Ethical oversight was confirmed by the Paso del Norte Health Information Exchange. No competing interests were declared in the source document.